drug · gene
detalimogene voraplasmid
Phase 2updated 6mo agoby $ENGN enGene Therapeutics Inc.🔗 ChEMBL
Phase 2community read0 votes
Gene drug with a maximum clinical stage of Phase 1 2 (across all indications), with 2 investigational indications.
all catalysts(0)
nothing on the calendar yet
News(3)
- Milestone cutting 20% of HQ team, including CMOFollow along as BioSpace tracks job cuts and restructuring initiatives.biospace · 1d ago
- Chutes & Ladders—Bristol Myers' research chief out amid R&D reorganizationBristol Myers Squibb's research chief is departing as the company restructures R&D. Summit Therapeutics cut ties with multiple launch team members, including its CCO, ahead of a high-stakes FDA dec…fiercebiotech · 3d ago
- Detalimogene Voraplasmid Yields 54% CR Rate in Heavily Pretreated BCG-Unresponsive NMIBC With CISTRAEs were generally reversible and low grade, and 96.8% of patients remained free from progression to T2 or greater disease at the data cutoff.onclive · 6mo ago
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that